Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-17-065245

Director acquired 250,000 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
FLATLEY JAY T Director 2017-12-12 Conversion +250,000 250,000 I
Derivatives
FLATLEY JAY T Director 2017-12-12 Conversion · Series A-1 Preferred Stock −250,000 0 I
Loading xslF345X03/doc4.xml…